Silence Therapeutics plc (SLN) Tops Q1 EPS by 3c

Silence Therapeutics plc (NASDAQ: SLN) reported Q1 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $1.32 million.

For earnings history and earnings-related data on Silence Therapeutics plc (SLN) click here.

You May Also Be Interested In

• Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
• PepsiCo (PEP) call put ratio 1.8 calls 1 put with a focus on October calls as share price near low end of range
• Lightspeed POS Inc. (LSPD)Assumed at Equalweight at Morgan Stanley